A2ADY9
Gene name |
Ddi2 |
Protein name |
Protein DDI1 homolog 2 |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:68817 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for A2ADY9
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A2ADY9-F1 | Predicted | AlphaFoldDB |
21 variants for A2ADY9
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs254133516 | 43 | A>P | No | EVA | |
| rs254133516 | 43 | A>S | No | EVA | |
| rs3388726240 | 51 | E>* | No | EVA | |
| rs3388723132 | 104 | T>R | No | EVA | |
| rs3388713863 | 107 | P>L | No | EVA | |
| rs3388725286 | 131 | G>A | No | EVA | |
| rs3388729498 | 152 | L>M | No | EVA | |
| rs3388723161 | 158 | P>S | No | EVA | |
| rs3388719738 | 162 | A>T | No | EVA | |
| rs3388732894 | 168 | L>H | No | EVA | |
| rs3388723172 | 228 | E>G | No | EVA | |
| rs3388735143 | 316 | Q>K | No | EVA | |
| rs3388725208 | 328 | K>R | No | EVA | |
| rs3388719705 | 339 | N>I | No | EVA | |
| rs3388719752 | 344 | G>D | No | EVA | |
| rs3388723107 | 346 | T>M | No | EVA | |
| rs3388722782 | 349 | Q>R | No | EVA | |
| rs3388725176 | 352 | F>L | No | EVA | |
| rs3388729435 | 361 | C>Y | No | EVA | |
| rs3388726259 | 370 | R>G | No | EVA | |
| rs3388735141 | 379 | A>V | No | EVA |
No associated diseases with A2ADY9
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| chromosome | A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| aspartic-type endopeptidase activity | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile. |
| identical protein binding | Binding to an identical protein or proteins. |
| ubiquitin binding | Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| cellular response to hydroxyurea | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyurea stimulus. |
| proteasomal protein catabolic process | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome. |
| protein processing | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. |
| regulation of DNA stability | Any process that modulates the stability of DNA. |
| regulation of protein stability | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MLLTVYCVRR | DLSEVTFSLQ | VDADFELHNF | RALCELESGI | PAAESQIVYA | ERPLTDNHRS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LASYGLKDGD | VVILRQKENA | DPRPAVQFSN | LPRIDFSSIA | VPGTSNPQQR | QLPRTQAQHS |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SPGEMASSPQ | GLDNPALLRD | MLLANPHELS | LLKERNPPLA | EALLSGDLEK | FSRVLVEQQQ |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DRARREQERI | RLFSADPFDL | EAQAKIEEDI | RQQNIEENMT | IAMEEAPESF | GQVAMLYINC |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RVNGHPVKAF | VDSGAQMTIM | SQACAERCNI | MRLVDRRWAG | IAKGVGTQKI | IGRVHLAQVQ |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IEGDFLACSF | SILEEQPMDM | LLGLDMLKRH | QCSIDLKKNV | LVIGTTGSQT | TFLPEGELPE |
| 370 | 380 | 390 | |||
| CARLAYGTGR | EDIRPEEIAD | QELAEAIQKS | AEDAERQKP |